Financial Reporting - May 2025

Limited and B Limited are engaged in the manufacture of pharmaceuticals. On 1% June, 2024, A Limited acquired 15% of equity shares of B Limited. On 1% October, 2024, A Limited obtains control of B Limited when it acquires a further 55% of B Limited’s shares, thereby resulting into a total holding of 10%. The fair value of the shares of B Limited was % 40 per share as on that date. Prior to the acquisition of additional 55% stake…